James F Trotter

Summary

Affiliation: Baylor University Medical Center
Country: USA

Publications

  1. doi request reprint Renal dysfunction and the liver transplant recipient; novel strategies for determination of reversibility and renal protective therapies pretransplant and posttransplant
    James Trotter
    Baylor University Medical Center, Dallas, Texas, USA
    Curr Opin Organ Transplant 17:225-9. 2012
  2. doi request reprint Hot-topic debate on hepatitis C virus: the type of immunosuppression matters
    James F Trotter
    Baylor University Medical Center, Dallas, TX 75246, USA
    Liver Transpl 17:S20-3. 2011
  3. pmc Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study
    James F Trotter
    Department of Surgery, University of Colorado, Aurora, CO, USA
    Liver Transpl 17:409-17. 2011
  4. pmc Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study
    Jeffrey Campsen
    Division of Transplant Surgery, University of Colorado, Aurora, CO 80262, USA
    Liver Transpl 14:1273-80. 2008
  5. ncbi request reprint Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications
    Jeffrey C Dunkelberg
    Division of Gastroenterology Hepatology, University of Colorado Health Sciences Center, Denver, CO, USA
    Liver Transpl 9:463-8. 2003
  6. ncbi request reprint Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection
    Marcelo Kugelmas
    Divisions of Gastroenterology Hepatology, University of Colorado, Denver, CO 80262, USA
    Liver Transpl 9:1159-65. 2003
  7. ncbi request reprint Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation
    Paul H Hayashi
    Division of Gastroenterology, University of Colorado Health Sciences Center, Denver, CO, USA
    Am J Transplant 4:782-7. 2004
  8. pmc Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation
    Robert M Merion
    Department of Surgery, University of Michigan, Ann Arbor, MI, USA
    Ann Surg 251:542-9. 2010
  9. ncbi request reprint Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD
    Paul H Hayashi
    Hepatology Section, University of Colorado Health Sciences Center, Denver, CO, USA
    Liver Transpl 10:42-8. 2004
  10. doi request reprint Utilization of hepatitis C antibody-positive livers: genotype dominance is virally determined
    Jacqueline G O'Leary
    Annette C and Harold C Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX 75246, USA
    Transpl Int 25:825-9. 2012

Collaborators

Detail Information

Publications26

  1. doi request reprint Renal dysfunction and the liver transplant recipient; novel strategies for determination of reversibility and renal protective therapies pretransplant and posttransplant
    James Trotter
    Baylor University Medical Center, Dallas, Texas, USA
    Curr Opin Organ Transplant 17:225-9. 2012
    ..Renal dysfunction is one of the most common and important complications in liver transplant candidates and recipients. Recent publications have highlighted important developments in this field...
  2. doi request reprint Hot-topic debate on hepatitis C virus: the type of immunosuppression matters
    James F Trotter
    Baylor University Medical Center, Dallas, TX 75246, USA
    Liver Transpl 17:S20-3. 2011
    ..4. Because insulin resistance and diabetes are associated with fibrosis in HCV-infected liver transplant recipients, the use of immunosuppressive agents without this side effect may slow the posttransplant disease progression...
  3. pmc Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study
    James F Trotter
    Department of Surgery, University of Colorado, Aurora, CO, USA
    Liver Transpl 17:409-17. 2011
    ..Persistently decreased platelet counts warrant further investigation...
  4. pmc Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study
    Jeffrey Campsen
    Division of Transplant Surgery, University of Colorado, Aurora, CO 80262, USA
    Liver Transpl 14:1273-80. 2008
    ..Five of the 10 living donors had a total of 7 posttransplant complications. In conclusion, LDLT is rarely performed for ALF, but in selected patients it may be associated with acceptable recipient mortality and donor morbidity...
  5. ncbi request reprint Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications
    Jeffrey C Dunkelberg
    Division of Gastroenterology Hepatology, University of Colorado Health Sciences Center, Denver, CO, USA
    Liver Transpl 9:463-8. 2003
    ..The prevalence of wound and hepatic artery complications is not different in liver transplant recipients administered sirolimus as part of a primary immunosuppressive regimen compared with historic controls...
  6. ncbi request reprint Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection
    Marcelo Kugelmas
    Divisions of Gastroenterology Hepatology, University of Colorado, Denver, CO 80262, USA
    Liver Transpl 9:1159-65. 2003
    ..0006). In conclusion, IS levels decreased significantly in patients responding favorably to anti-HCV therapy. This decrease in IS levels may have a key role in predisposing these patients to ACR...
  7. ncbi request reprint Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation
    Paul H Hayashi
    Division of Gastroenterology, University of Colorado Health Sciences Center, Denver, CO, USA
    Am J Transplant 4:782-7. 2004
    ..This balance is influenced greatly by the MELD system's determination of waiting times for HCC patients...
  8. pmc Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation
    Robert M Merion
    Department of Surgery, University of Michigan, Ann Arbor, MI, USA
    Ann Surg 251:542-9. 2010
    ..To compare rates of hospitalization before and after adult-to-adult living donor liver transplant (LDLT) and deceased donor liver transplant (DDLT)...
  9. ncbi request reprint Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD
    Paul H Hayashi
    Hepatology Section, University of Colorado Health Sciences Center, Denver, CO, USA
    Liver Transpl 10:42-8. 2004
    ..More stringent HCC diagnostic criteria will be required to decrease the effect that misdiagnosis has on organ allocation...
  10. doi request reprint Utilization of hepatitis C antibody-positive livers: genotype dominance is virally determined
    Jacqueline G O'Leary
    Annette C and Harold C Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX 75246, USA
    Transpl Int 25:825-9. 2012
    ..In conclusion, approximately half of HCV antibody-positive donors were aviremic. Viral dominance in viremic donor-recipient pairs seems virally determined...
  11. pmc Donor morbidity after living donation for liver transplantation
    Rafik M Ghobrial
    Department of Surgery, University of California Los Angeles, Los Angeles, California, USA
    Gastroenterology 135:468-76. 2008
    ..The rate and severity of complications in living donors were investigated in the 9-center Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL)...
  12. doi request reprint Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course
    Jeffrey Campsen
    Division of Transplant Surgery, University of Colorado Health Sciences Center, Denver, CO, USA
    Liver Transpl 14:181-5. 2008
    ..6-50.6 months). In conclusion, recurrent PSC following OLT is a formidable but protracted problem following OLT. Patients may require a second transplant following reemergent disease with reasonable survival benefit...
  13. doi request reprint Early use of renal-sparing agents in liver transplantation: a closer look
    James F Trotter
    Baylor University Medical Center, Dallas, TX 75246, USA
    Liver Transpl 19:826-42. 2013
    ....
  14. doi request reprint A comparison of outcomes between OKT3 and antithymocyte globulin for treatment of steroid-resistant rejection in hepatitis C liver transplant recipients
    Mina M Benjamin
    1 Internal Medicine Department, Baylor University Medical Center, Dallas, TX 2 Division of Gastroenterology, Internal Medicine Department, Baylor University Medical Center, Dallas, TX 3 Address correspondence to Mina M Benjamin, M D, Internal Medicine Department, Baylor University Medical Center, 3500 Gaston Avenue, Dallas, TX 75246
    Transplantation 97:470-3. 2014
    ..After OKT3 was recently withdrawn from the market, thymoglobulin (TG) became the principal treatment for SRR...
  15. doi request reprint Corticosteroid elimination in simultaneous liver-kidney transplantation recipients
    Nicholas K Weber
    Division of Gastroenterology and Hepatology, University of Colorado Health Sciences Center, Aurora, CO, USA
    Clin Transplant 23:958-63. 2009
    ..While less common in kidney transplant alone recipients (KTA), corticosteroid discontinuation is performed routinely in liver transplantation, raising the question of optimal immunosuppression for SLK recipients...
  16. pmc Outcomes of donor evaluation in adult-to-adult living donor liver transplantation
    James F Trotter
    Department of Surgery, University of Colorado, Denver, CO, USA
    Hepatology 46:1476-84. 2007
    ..Other predictors of donor acceptance included earlier year of evaluation and transplant center...
  17. ncbi request reprint Comprehensive cost comparison of adult-adult right hepatic lobe living-donor liver transplantation with cadaveric transplantation
    James F Trotter
    Division of Gastroenterology Hepatology, University of Colorado, Denver, CO 80262, USA
    Transplantation 75:473-6. 2003
    ..In this study, we compare the comprehensive cost of LDLT with that of cadaveric-liver transplantation...
  18. doi request reprint International normalized ratio of prothrombin time in the model for end-stage liver disease score: an unreliable measure
    Russ Arjal
    Division of Gastroenterology Hepatology, University of Colorado Health Sciences Center, 1635 N Ursula, B 154, Aurora, CO 80045, USA
    Clin Liver Dis 13:67-71. 2009
    ....
  19. doi request reprint Sirolimus and cardiovascular disease risk in liver transplantation
    Greg J McKenna
    Department of Surgery, Baylor University Medical Center, Dallas, TX 75246, USA
    Transplantation 95:215-21. 2013
    ..There are no published reports of sirolimus CVD in liver transplantation...
  20. pmc Severe psychiatric problems in right hepatic lobe donors for living donor liver transplantation
    James F Trotter
    Department of Surgery, University of Colorado, Denver, CO 80262, and Department of Transplant Services, Piedmont Hospital, Atlanta, GA, USA
    Transplantation 83:1506-8. 2007
    ....
  21. ncbi request reprint Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients
    James F Trotter
    Division of Gastroenterology Hepatology, University of Colorado Health Sciences Center, Denver, CO, USA
    Liver Transpl 8:212-8. 2002
    ....
  22. doi request reprint Long-term follow-up of liver transplantation for Budd-Chiari syndrome with antithrombotic therapy based on the etiology
    Srinath Chinnakotla
    Baylor Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX 75246, USA
    Transplantation 92:341-5. 2011
    ....
  23. ncbi request reprint Living donor liver transplantation and hepatitis C
    Aaron C Baltz
    University of Colorado, Health Sciences Center, Division of Gastroenterology Hepatology, 4200 E 9th Avenue, Rm B 154 Denver, CO 80262, USA
    Clin Liver Dis 7:651-65, viii. 2003
    ..The optimum clinical approach is to only consider living donor liver transplantation in HCV-infected recipients as a life-saving procedure and to attempt to eradicate HCV before transplantation to prevent recurrent infection...
  24. doi request reprint HBIg discontinuation with maintenance oral anti-viral therapy and HBV vaccination in liver transplant recipients
    Nicholas K Weber
    Division of Gastroenterology and Hepatology, University of Colorado Health Sciences Center, 1635 N Ursula, Aurora, CO 80045, USA
    Dig Dis Sci 55:505-9. 2010
    ..Recurrence prophylaxis is typically long-term hepatitis B immune-globulin (HBIg) and an oral anti-HBV agent. Because of high HBIg costs and improving efficacy of new oral agents, there is increasing interest in HBIg discontinuation...
  25. doi request reprint Intensive care unit management of liver-related coagulation disorders
    Kevin Dasher
    Baylor University Medical Center, Dallas, TX 75246, USA
    Crit Care Clin 28:389-98, vi. 2012
    ..This article reviews the background of coagulopathy in patients with end-stage liver disease and management options and comments on common clinical scenarios...
  26. ncbi request reprint Practical management of acute liver failure in the Intensive Care Unit
    James F Trotter
    Transplantation, Baylor University Medical Center, Dallas, Texas 75246, USA
    Curr Opin Crit Care 15:163-7. 2009
    ..This review focuses on the practical aspects of the management of patients with acute liver failure in the ICU...